Influence of administration time and sex on natriuretic, diuretic, and kaliuretic effects of diuretics.
利尿劑的給藥時間和性別對利尿、排鉀和排鉀效果的影響。
Am J Physiol Renal Physiol 2023-03-03
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Tolvaptan在患有晚期慢性腎臟病和急性失代償性心臟衰竭患者中與低急性腎損傷風險的關聯。
Am J Nephrol 2023-11-09
Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.
急性心衰患者中乙酰唑胺和鈉葡萄糖共同運輸蛋白2抑制劑的相似之處和區別:對ADVOR和EMPULSE的重要見解。
Eur J Heart Fail 2023-10-23
Use of furosemide in preterm neonates with acute kidney injury is associated with increased mortality: results from the TINKER registry.
早產兒急性腎損傷使用呋塞米與增加死亡率相關:TINKER 註冊資料庫的結果。
Pediatr Nephrol 2024-02-04
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD.
慢性腎臟病和2型糖尿病患者中 finerenone 的藥物動力學和藥效學:基於 FIGARO-DKD 和 FIDELIO-DKD 的見解。
Diabetes Obes Metab 2024-02-08
Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.
脫水性心衰竭患者中添加 empagliflozin 與加倍 furosemide 劑量的比較分析。
Cardiovasc Drugs Ther 2024-06-12
Emerging Role of Low-dose Loop Diuretics in the Management of Heart Failure Patients to Maintain Euvolemia.
低劑量環利尿劑在心衰竭患者維持正常血容量管理中的新興角色。
J Assoc Physicians India 2024-09-18